DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,053 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $256,596 | -0.8% | 1,027 | -0.9% | 0.07% | -2.8% |
| Q1 2024 | $258,710 | +19.7% | 1,036 | +10.9% | 0.07% | +29.1% |
| Q4 2023 | $216,072 | -5.5% | 934 | +1.3% | 0.06% | -21.4% |
| Q3 2023 | $228,748 | -25.0% | 922 | -27.5% | 0.07% | -18.6% |
| Q2 2023 | $305,040 | -97.4% | 1,271 | -96.5% | 0.09% | -95.7% |
| Q4 2021 | $11,809,000 | +11.2% | 35,895 | +2.9% | 2.00% | -4.5% |
| Q3 2021 | $10,615,000 | +13.4% | 34,868 | -0.0% | 2.09% | +7.2% |
| Q2 2021 | $9,361,000 | +19.3% | 34,885 | +0.0% | 1.95% | +4.7% |
| Q1 2021 | $7,848,000 | +1.3% | 34,868 | -0.0% | 1.86% | -6.4% |
| Q4 2020 | $7,746,000 | +2.2% | 34,872 | -0.9% | 1.99% | -10.0% |
| Q3 2020 | $7,578,000 | -35.9% | 35,196 | -47.4% | 2.21% | -22.3% |
| Q2 2020 | $11,828,000 | +27.6% | 66,891 | -0.1% | 2.84% | -10.0% |
| Q1 2020 | $9,266,000 | -9.8% | 66,947 | 0.0% | 3.16% | +9.3% |
| Q4 2019 | $10,275,000 | – | 66,947 | – | 2.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |